Sangamo Therapeutics
Translating ground-breaking science into genomic therapies. Learn more
Launch date
Employees
Market cap
AUD261m
Enterprise valuation
AUD263m (Public information from Sep 2024)
Share price
$0.84 SGMO
Company register number 03756817
Richmond Virginia (HQ), Brisbane United States (HQ)
Authorizing premium user...